講座題目：視頻率高光譜成像使光譜超視覺成為可能:臨床診斷與外科中的一項顛覆性技術

Video-Rate Hyperspectral Imaging Enables Spectral Hyper Vision: A Game-Changing Technology in Clinical Diagnosis and Surgery

報 告 人：Costas Balas

時 　 間：2019年11月21日(周四)10:00-12:00

地 　 點：中關村校區研究生教學樓101報告廳

主辦單位：研究生院、信息與電子學院

報名方式：登錄北京理工大學微信企業號---第二課堂---課程報名中選擇“【百家大講堂】第279期：視頻率高光譜成像使光譜超視覺成為可能:臨床診斷與外科中的一項顛覆性技術”

【主講人簡介】

  Costas Balas在希臘佩特雷大學獲得醫學物理和生物醫學工程的物理學位和博士學位。他是希臘查尼亞克里特島技術大學電子與計算機工程學院(ECE)的教授，是ECE學院電子實驗室主任和實驗室光子學集團的創始人和領導。他的研究興趣包括生物光子學和高光譜成像。Balas教授曾在9家期刊擔任主編/編委，在國際會議上做過50多次邀請/全體會議演講，發表過100多篇文章和書籍章節，并擁有多項專利。

Costas Balas received the Physics Degree and the PhD in Medical Physics and Biomedical Engineering, both from the University of Patras Greece. He is a Professor in the School of Electrical and Computer Engineering (ECE) at the Technical University of Crete, Chania, Greece. He is the Director of the ECE School Electronics Lab and the founder and leader of Lab’s photonics group. His research interests span both biophotonics and hyperspectral imaging. Costas Balas has served as Gest Editor/Editorial Board Member in 9 journals, given more than 50 invited/plenary talks in international conferences, and published more than 100 per-reviewed articles and book chapters.

  本次報告將著重介紹理想高光譜成像系統的新發展。報告將首先介紹一種結合了幾乎實時的光譜分類算法以及以視頻速率顯示的整個系統輸出光譜圖的先進的、小型化的硬件配置。這是一種新興的技術，光譜超視覺，有望從根本上提高診斷和手術治療的準確性。報告還將介紹新一代的皮膚鏡、內窺鏡和婦科顯微鏡，并展示國際臨床試驗的結果，證實其優于傳統方法。

This talk will emphasize on new developments towards an ideal hyperspectral imaging system. The talk will firstly present an advanced, miniaturized hardware configuration, combined with nearly real time spectral classification algorithms, with the total system outputting spectral maps displayed at video rates. This is synonymous to spectral hyper vision , an emerging technology holding the promise to radically improve the diagnostic and surgical treatment accuracy outcomes in several medical practices. A new generation of skin scopes, endoscopes and gynecologic microscopes, implementing this new technology will be presented, together with results from international clinical trials confirming superior performance over traditional methods.